NCT07088913 A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants Status COMPLETED Phase PHASE1
NCT07082738 A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease Status RECRUITING Phase PHASE2
NCT07081633 Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07073950 A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation Status RECRUITING Phase PHASE4
NCT07073547 A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2) Status RECRUITING Phase PHASE1
NCT07070128 Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer Status RECRUITING Phase N/A
NCT07069829 Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo Status RECRUITING Phase N/A
NCT07069725 The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis. Status RECRUITING Phase PHASE1
NCT07069712 A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma Status RECRUITING Phase PHASE2
NCT07069595 PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease Status RECRUITING Phase PHASE2
NCT07065344 A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region Status NOT_YET_RECRUITING Phase N/A
NCT07064122 A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers) Status RECRUITING Phase PHASE1
NCT07060365 A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT07058519 A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC Status RECRUITING Phase PHASE2
NCT07052578 Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration Status RECRUITING Phase N/A
NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) Status RECRUITING Phase PHASE3
NCT07041606 An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation Status RECRUITING Phase N/A
NCT07038928 TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation Status RECRUITING Phase N/A